Indo Rama

Indorama Ventures is a global leader in the production of intermediate petrochemicals and specialty materials, with a significant presence in the healthcare and life sciences sectors. The company's Life Sciences division, bolstered by the acquisition of Oxiteno, provides high-purity surfactants and excipients used in pharmaceutical formulations and drug delivery systems. Additionally, its Hygiene segment produces non-woven fabrics for medical and personal care applications, while its Packaging segment supplies PET resins for medical-grade containers. As a key upstream supplier, Indorama Ventures supports the pharmaceutical industry through the manufacturing of essential chemical building blocks and specialized materials. The company operates a vast global manufacturing network, ensuring the supply of critical components for medical devices and hygiene products. While not a drug discovery firm, Indorama Ventures is an essential partner in the healthcare supply chain, focusing on material science and chemical innovation.